Liver transplant complications in hepatitis C infected recipients: recurrence versus rejection

References

• Kim WR, Stock PG, Smith JM, et al. OPTN/SRTR 2011 annual data report: liver. Am J Transplant 2013;13(Suppl 1):73-102
   PubMedGoogle Scholar
• Shemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004;113(4):825-32
   PubMedGoogle Scholar
• Turner AP, Knechtle SJ. Induction immunosuppression in liver transplantation: a review. Transpl Int 2013;26(7):673-83
   PubMed Web of Science ®Google Scholar
• Neumann U, Samuel D, Trunecka P, et al. A randomized multicenter study comparing a tacrolimus-based protocol with and without steroids in HCV-positive liver allograft recipients. J Transplant 2012;2012:894215
   PubMedGoogle Scholar
• Petrovic LM, Villamil FG, Vierling JM, et al. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transpl Surg 1997;3(4):398-406
   PubMedGoogle Scholar
• Regev A, Molina E, Moura R, et al. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl 2004;10(10):1233-9
   PubMedGoogle Scholar
• Massoud O, Heimbach J, Viker K, et al. Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay. Liver Transpl 2011;17(6):723-32
   PubMedGoogle Scholar
• Schmeding M, Dankof A, Krenn V, et al. C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant 2006;6(3):523-30
   PubMedGoogle Scholar
• Jain A, Ryan C, Mohanka R, et al. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies. Clin Transplant 2006;20(5):624-33
   PubMedGoogle Scholar
• Schmeding M, Kienlein S, Rocken C, et al. ELISA-based detection of C4d after liver transplantation -- a helpful tool for differential diagnosis between acute rejection and HCV-recurrence? Transpl Immunol 2010;23(4):156-60
   PubMedGoogle Scholar
• Fayek SA. The value of C4d deposit in post liver transplant liver biopsies. Transpl Immunol 2012;27(4):166-70
   PubMedGoogle Scholar
• MacQuillan GC, de Boer WB, Allan JE, et al. Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation. Clin Transplant 2010;24(2):252-8
   PubMedGoogle Scholar
• Unitt E, Gelson W, Davies SE, et al. Minichromosome maintenance protein-2-positive portal tract lymphocytes distinguish acute cellular rejection from hepatitis C virus recurrence after liver transplantation. Liver Transpl 2009;15(3):306-12
   PubMedGoogle Scholar
• Cabrera R, Ararat M, Soldevila-Pico C, et al. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transpl 2009;15(2):216-22
   PubMedGoogle Scholar
• Gehrau R, Mas V, Archer K, Maluf D. Biomarkers of disease differentiation: HCV recurrence versus acute cellular rejection. Fibrogenesis Tissue Repair 2012;5(Suppl 1):S11
   PubMedGoogle Scholar
• Gehrau R, Maluf D, Archer K, et al. Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients. Mol Med 2011;17(7-8):824-33
   PubMedGoogle Scholar
• Sreekumar R, Rasmussen DL, Wiesner RH, Charlton MR. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation. Liver Transpl 2002;8(9):814-21
   PubMedGoogle Scholar
• Asaoka T, Kato T, Marubashi S, et al. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation. Liver Transpl 2009;15(12):1738-49
   PubMedGoogle Scholar
• Joshi D, Salehi S, Brereton H, et al. Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation. Liver Transpl 2013;19(4):383-94
   PubMedGoogle Scholar
• Farid WR, Pan Q, van der Meer AJ, et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 2012;18(3):290-7
   PubMed Web of Science ®Google Scholar